PDL BioPharma, Inc. Acquisition Costs, Period Cost
PDL BioPharma, Inc. reported Acquisition Costs, Period Cost of $20.00 million for the 0-month period ending 2018-08-02, per its 10-Q filed 2018-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AcquisitionCosts · last filed 2018-08-09
- 2018-08-02: Acquisition Costs, Period Cost 0 month $20.00M.
| Period end | Acquisition Costs, Period Cost 0 month |
|---|---|
| 2018-08-02 | $20.00M 10-Q · filed 2018-08-09 |